Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 2 receptor beta (IL2RB) is a type I membrane protein that forms part of the interleukin-2 receptor complex. It plays a central role in T cell-mediated immune responses and exists in three forms with varying affinities for its ligand, interleukin 2 (IL-2). The β and γ chains are responsible for signal transduction; the α chain increases ligand binding affinity but does not participate in signaling. Additionally, this protein also serves as one of three subunits forming the functional interleukin‑15 receptor. Mutations or defects in IL2RB can cause severe immune dysregulation. Soluble forms or altered levels have been linked to disease severity in conditions like COVID‐19 and abdominal aortic aneurysms.
Mediates signal transduction upon binding of interleukin-2, leading to activation of JAK/STAT pathways and cellular proliferation/differentiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 2 Receptor Beta (IL2RB).